Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Regeneron Pharmaceuticals is planning to establish a biomedical research facility in Suffern, N.Y. The company recently invested $39 million to acquire the 235,000-sf Avon Innovation Center. Sited on 10 acres, the three-story structure originally housed chemistry labs and support spaces for the development of cosmetics, fragrances, and skincare products. HLW designed the facility, which was constructed between 2003 and 2005 by Skanska USA Building.
Colorado School of Mines opened the $19.4 million Labriola Innovation Hub in February of 2024 in Golden, Colo. Designed by OZ Architecture, the 37,260-sf building features collaborative project studios and maker spaces where faculty, students, alumni, and industry partners can discover new solutions for critical societal problems. This campus-wide resource for invention supports both physical and computational approaches to ideation, prototyping, and testing.
Providence Health Care is planning to construct the CAD$638 million Clinical Support and Research Centre in Vancouver. Designed by Diamond Schmitt Architects and Kirsten Reite Architecture, the 370,000-sf facility will collocate world-class research labs with specialty physician practices to accelerate the translation of medical discoveries into solutions for patient care. Collaboration spaces will be intentionally woven throughout the building to promote interdisciplinary exchange between researchers, clinicians, and industry partners.
The University of Nevada, Las Vegas opened the $73 million Advanced Engineering Building in February of 2024. Designed by SmithGroup in association with PGAL, the 52,000-sf facility will enable the Howard R. Hughes College of Engineering to increase total enrollment from 3,000 to 5,000 students to address a national need for skilled professionals. On the ground floor, a flexible classroom is strategically sited next to a maker space to foster the application of academic knowledge to hands-on exploration.
AstraZeneca is investing $300 million to establish a cell therapy manufacturing facility in Rockville, Md. Developed by Alexandria Real Estate Equites, the Class A+ property is located in the vibrant innovation ecosystem of the Alexandria Center for Life Science at Shady Grove. AstraZeneca has executed a 13-year lease for the entire 84,264-rsf building.